BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CERN//INDICO//EN
BEGIN:VEVENT
SUMMARY:Comparison of tangential-intensity modulated radiotherapy (t-IMRT)
  and volumetric modulated arc therapy (VMAT) for different sizes of left b
 reast cancer
DTSTART;VALUE=DATE-TIME:20260518T123300Z
DTEND;VALUE=DATE-TIME:20260518T124100Z
DTSTAMP;VALUE=DATE-TIME:20260624T105828Z
UID:indico-contribution-3815@indico.tlabs.ac.za
DESCRIPTION:Speakers: Abuobaida Ahmed (North-West University)\nBackground:
  Radiotherapy is an essential part of the management of left-sided breast 
 cancer\, and this requires an optimal balance in target volume coverage an
 d organs at risk\, such as the ipsilateral lung and the heart. Advanced te
 chniques such as tangential-intensity modulated radiotherapy (t-IMRT) and 
 volumetric modulated arc therapy (VMAT) are commonly used. However\, the d
 osimetric performance of t-IMRT and VMAT for varying breast sizes has been
  poorly characterized. \nAim: To compare the effectiveness of tangential-I
 MRT and VMAT for hypo-fractionated left-sided breast cancers across small\
 , medium\, and large breast sizes.\nMaterials & Methods: A total of 30 CT 
 datasets from female patients with left-sided breast cancer\, acquired bet
 ween 2020 and 2025\, were analyzed. Patients were divided into groups base
 d on breast volume\, with a mean volume of 781.00 cc. For each patient\, t
 wo treatment plans were designed using the Monaco treatment planning syste
 m\, which uses the Monte Carlo method. A dose of 26 Gy in 5 fractions was 
 prescribed according to the FAST-Forward hypo-fractionated protocol. Evalu
 ation of the dosimetric parameters included the Planning Target Volume (PT
 V) coverage indices D2%\, D5%\, D95%\, Homogeneity Index (HI)\, Conformity
  Index (CI)\, and doses to the heart (V7 and V1.5 Gy)\, as well as the ips
 ilateral lung volume receiving V8 Gy. A two-way ANOVA was performed\, with
  a significance (p < 0.05).\nResults: VMAT showed superior target coverage
 \, conformity\, and dose homogeneity compared to t-IMRT across all breast 
 sizes (p < 0.05). PTV D95% coverage with the VMAT plans was 99.8%\, 98.3%\
 , and 97.0% for small\, medium\, and large breasts\, respectively\, wherea
 s the t-IMRT plans failed to achieve the required coverage of ≥95% and r
 esulted in 89.2-90.0% coverage across all the breast sizes. Also\, the hom
 ogeneity and conformity indices were improved with the VMAT plan. Both pla
 ns satisfied the PTV hotspot constraints of D2% < 107% and D5% < 105%. Alt
 hough the t-IMRT plans resulted in lower hotspot doses for small and mediu
 m breasts\, the VMAT plans resulted in slightly better hotspot dose contro
 l for large breasts. However\, the differences were not clinically signifi
 cant\, as they were within 1%. However\, the t-IMRT plans resulted in supe
 rior OAR sparing\, with lower ipsilateral lung V8 Gy and lower high-dose c
 ardiac exposure (Heart V1.5  Gy: 0.9 - 1.1 Gy)\, compared to the VMAT plan
 s\, which resulted in higher high-dose cardiac exposure (2.9 - 3.3 Gy)\, e
 xceeding the tolerance limit\, though the VMAT plans resulted in lower low
 -dose cardiac exposure (Heart V7 Gy).\nConclusion: VMAT provided superior 
 target coverage\, conformity\, and homogeneity across all breasts compared
  to t-IMRT\, achieving the required PTV D95% ≥ 95% in all cases. Both te
 chniques were able to meet the PTV hotspot requirements\, with slightly im
 proved control for larger breasts with VMAT\, while this may not have a cl
 inically significant impact. However\, t-IMRT showed superior sparing of O
 ARs\, particularly the ipsilateral lung and high-dose cardiac areas. In co
 ntrast\, VMAT showed increased dose to high-dose cardiac areas and decreas
 ed dose to low-dose cardiac areas.\nKeywords: VMAT\, Tangential-IMRT\, Lef
 t-sided Breast radiotherapy\, Breast sizes\, UK FSAT-Forward protocol.\n\n
 https://indico.tlabs.ac.za/event/139/contributions/3815/
LOCATION:NRF-iThemba LABS\, Old Faure Road\, Cape Town Auditorium
URL:https://indico.tlabs.ac.za/event/139/contributions/3815/
END:VEVENT
END:VCALENDAR
